arrow
B

Bruno Sepodes

Universidade de Lisboa
H指数:37
被引数:4,257

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of treatments for sarcopenia: new challenges, opportunities and perspectives

治疗肌少症的发展:新的挑战、机遇和展望

2026-11-160
PRE
European Medicines Agency multi-stakeholder workshop on innovation in cardiovascular medicines and medical devices in the EU

欧洲药品管理局关于欧盟心血管药物和医疗器械创新的多利益相关方研讨会

2026-07-220
OA
The European Medicines Agency's review of elexacaftor/ tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I CFTR variants

欧洲药品管理局对Kaftrio(elexacaftor-tezacaftor-ivacaftor)的审查:将其适用范围扩展至所有年龄在2岁及以上且不携带两种class I CFTR变异的CF患者。

2026-01-011
PRE
Novel approaches to the stratified management of knee osteoarthritis

分层管理膝关节骨关节炎的新方法

2025-10-030
PRE